Biotech Leads Biolabs Receives Orphan Drug Designation from the US FDA for LBL-034, a Uniquely Designed, Highly Differentiated Anti-GPRC5D/CD3 Bispecific Antibody, for the Treatment of Multiple Myeloma November 6, 2024
Biotech NorthWest EHealth (NWEH) announces a pilot to test a new model for finding and recruiting participants for clinical trials using the Clinical Practice Research Datalink November 5, 2024
Biotech Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) November 4, 2024
Biotech Cadrenal Therapeutics Announces Exercise of Warrants for $4.7 Million Gross Proceeds November 3, 2024
Biotech Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) November 2, 2024
Biotech Kling Biotherapeutics to Present Key Applications for its Primary B-Cell Immortalization, Screening and Antibody Optimization Platform Technologies at PEGS Europe October 31, 2024
Biotech Ottimo Pharma Emerges from Stealth with Backing from Medicxi and Management Team Led by David Epstein to Accelerate Development of a Novel PD1/VEGFR2 Bi-Functional Antibody Planned to Enter the Clinic in 2025 October 28, 2024
Search
Biotech
November 6, 2024
November 5, 2024
November 4, 2024
November 3, 2024
November 2, 2024
November 1, 2024
October 31, 2024
October 30, 2024
October 29, 2024
October 28, 2024
